Why the study?
Does inogatran reduce ischemic events compared to heparin in patients with unstable coronary artery disease?
Does inogatran reduce ischemic events compared to heparin in patients with unstable coronary artery disease?
Inogatran, a selective thrombin inhibitor, was not more effective than heparin in preventing ischemic events in patients with unstable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Inogatran offers no ischemic benefit over heparin in unstable CAD; challenges presumed superiority of direct thrombin inhibition.
A 1997 study studied this question.